1. Simulect (Basiliximab) Product Information. Novartis 1998–2012
2. Simulect (Basiliximab) WC500053538 Scientific Discussion, EMEA, Nov 2005
3. Simulect (Basiliximab) WC500053543 Annex I, EMEA, updated July 2012
4. Simulect (Basiliximab) WC500131049 Assessment Report February 2011
5. McKeage K, McCormack PL (2010) Basiliximab. A review of its use as induction therapy in renal transplantation. Biodrugs 24:55–76